Maribavir for Cytomegalovirus Treatment in the Real World—Not a Silver Bullet
Sign Up to like & getrecommendations! Published in 2022 at "Open Forum Infectious Diseases"
DOI: 10.1093/ofid/ofac686
Abstract: TO THE EDITOR—Cytomegalovirus (CMV) infection remains a frequent cause of morbidity and mortality among stem-cell and solid organ transplant recipients, with devastating complications including graft failure and death [1, 2]. Limitations of existing anti-CMV agents… read more here.
Keywords: maribavir cytomegalovirus; maribavir; cmv infection; treatment ... See more keywords